Business Standard

Don’t miss the latest developments in business and finance.

Lincoln Pharmaceuticals consolidated net profit rises 27.83% in the September 2017 quarter

Bs_logoImage
Capital Market
Last Updated : Dec 13 2017 | 5:16 PM IST

Sales rise 20.71% to Rs 89.65 crore

Net profit of Lincoln Pharmaceuticals rose 27.83% to Rs 11.30 crore in the quarter ended September 2017 as against Rs 8.84 crore during the previous quarter ended September 2016. Sales rose 20.71% to Rs 89.65 crore in the quarter ended September 2017 as against Rs 74.27 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales89.6574.27 21 OPM %17.2115.56 -PBDT16.9313.19 28 PBT15.1211.91 27 NP11.308.84 28

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Dec 13 2017 | 4:53 PM IST

Next Story